Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Madhava Baikadi"'
Autor:
Jean Paul Bahary, George Rodrigues, Mahul B. Amin, Snehal Deshmukh, Susan Chafe, Jeff M. Michalski, Deborah Watkins Bruner, Daniel Hunt, Harold Lau, James M. Galvin, Malti Patel, Canhua Xiao, Madhava Baikadi, Howard M. Sandler, Marie Duclos, Walter R. Bosch
Publikováno v:
Cancer. 121:2422-2430
Purpose A preliminary report of patient reported outcomes (PROs) between men receiving high-dose radiation therapy (RT) on RTOG 0126, a phase III dose-escalation trial treated with either 3-dimensional conformal RT (3D-CRT) or intensity modulated RT
Autor:
Madhava Baikadi, Karen L. Reckamp, Krista Noonan, Christine M. Lovly, Janessa Laskin, Leora Horn, Gloria J. Morris
Publikováno v:
Seminars in Oncology. 40:e1-e8
t At times we encounter clinical problems for which there are no directly applicable evidence-based solutions, but we are compelled by circumstances to act. When doing so we rely on related evidence, general principles of best medical practice, and o
Autor:
Christopher Peters, Meghan Haggerty, Cheng B. Saw, Frank Battin, Madhava Baikadi, Janice McKeague
Publikováno v:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 41(4)
Dose or treatment planning management is necessary for the re-irradiation of intracranial relapses after focal irradiation, radiosurgery, or stereotactic radiotherapy. The current clinical guidelines for metastatic brain tumors are the use of focal i
Autor:
G. Morton, Madhava Baikadi, W. Robert Lee, Juanita Crook, Colleen A. Lawton, Michael Kuettel, Howard M. Sandler, Y. Yan, Michael Gillin, Selim Firat
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 82:e795-e801
Purpose External-beam radiation therapy combined with low—doserate permanent brachytherapy are commonly used to treat men with localized prostate cancer. This Phase II trial was performed to document late gastrointestinal or genitourinary toxicity
Autor:
Madhava Baikadi, Kathryn M. Greven, Michael Gillin, Colleen A. Lawton, K. Bae, W. Robert Lee, Howard M. Sandler, Gerard Morton, Selim Firat, Michael Kuettel
Publikováno v:
Cancer. 109:1506-1512
BACKGROUND The combination of external-beam radiotherapy and brachytherapy is used commonly to treat men with prostate cancer. In this analysis, the authors examined the rate of biochemical recurrence (BR) and late grade ≥3 genitourinary (GU) and g
Autor:
Deborah W, Bruner, Daniel, Hunt, Jeff M, Michalski, Walter R, Bosch, James M, Galvin, Mahul, Amin, Canhua, Xiao, Jean-Paul, Bahary, Malti, Patel, Susan, Chafe, George, Rodrigues, Harold, Lau, Marie, Duclos, Madhava, Baikadi, Snehal, Deshmukh, Howard M, Sandler
The authors analyzed a preliminary report of patient-reported outcomes (PROs) among men who received high-dose radiation therapy (RT) on Radiation Therapy Oncology Group study 0126 (a phase 3 dose-escalation trial) with either 3-dimensional conformal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3298c2a0408cfc24346730667a5628d1
https://europepmc.org/articles/PMC4490066/
https://europepmc.org/articles/PMC4490066/
Autor:
Michelle DeSilvio, Colleen A. Lawton, Michael Gillin, Kathryn M. Greven, Madhava Baikadi, Howard M. Sandler, Michael Kuettel, W. Robert Lee, Gerard Morton, Selim Firat
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 64:804-809
Purpose: To estimate the rate of acute and late Grade 3–5 genitourinary and gastrointestinal toxicity after treatment with external beam radiotherapy and permanent source brachytherapy in a multi-institutional, cooperative group setting. Methods an
Autor:
Michelle DeSilvio, Deborah Watkins Bruner, Madhava Baikadi, P. Kathryn Winter, G. Morton, Steven J. Feigenberg, Howard M. Sandler, Thomas M. Pisansky, W. Robert Lee, Colleen A. Lawton
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 62:956-964
Purpose: To prospectively assess health-related quality of life (HRQOL) during the first year after treatment with prostate brachytherapy (PB) alone for T1c-2a prostate cancer. Materials and Methods: Ninety-eight patients from 24 institutions were el
Autor:
Colleen A. Lawton, Michael Gillin, Kathryn M. Greven, W. Robert Lee, Michael Kuettel, Madhava Baikadi, Gerard Morton, Selim Firat, Kyounghwa Bae, Howard M. Sandler
Publikováno v:
Brachytherapy. 5(4)
Background To date, there are few descriptive analyses of postimplant dosimetry from multi-institutional clinical trials. The purpose of this report is to describe the postimplant dosimetry achieved in Radiation Therapy Oncology Group (RTOG) 0019. Me
Autor:
Michael Gillin, W. Dennis Foley, Madhava Baikadi, Gerard Morton, Roger W. Byhardt, Colleen A. Lawton, Bernadine F. Dunning, Geoffrey S. Ibbott, Jeff M. Michalski, Thomas T. Pisansky, F. Lopez
Publikováno v:
Brachytherapy. 5(3)
Purpose To report the quality assurance methodology used by the Radiation Therapy Oncology Group in the first cooperative group, multi-institution Phase II trial of transrectal ultrasound guided permanent radioactive implantation of the prostate for